Effect of inadequate care on diabetes complications and healthcare resource utilization during management of type 2 diabetes in the United States

References

• American Diabetes Association. Standards of medical care in diabetes. Dia Care. 2018;41:S3–S3.Supplement 1
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. National diabetes statistics report. 2022. Atlanta, GA, U.S. Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services
   Google Scholar
• American Diabetes Association. Economic Costs of Diabetes in the U.S. in 2017. Diabetes Care. Published online 2018 Mar 21;415:917–928.
   PubMed Web of Science ®Google Scholar
• Wang Z, Liu M. Life years lost associated with diabetes: an individually matched cohort study using the U.S. National Health Interview Survey data. Diabetes Res Clin Pract. 2016;118:69–76.
   PubMed Web of Science ®Google Scholar
• Delevry D, Ho A, Le QA. Association between processes of diabetes care and health care utilization in patients with diabetes: evidence from a nationally representative US sample. J Diabetes. 2021;13(1):78–88.
   PubMed Web of Science ®Google Scholar
• Villarroel MA, Vahratian A. Vaccination coverage among adults with diagnosed diabetes: United States,2015 . 2016;(265):8. Atlanta(GA): U.S. Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services; 2016.
   Google Scholar
• Jiménez-Garcia R, Lopez-de-andres A, Hernandez-Barrera V, et al. Influenza vaccination in people with type 2 diabetes, coverage, predictors of uptake, and perceptions. Result of the MADIABETES cohort a 7 years follow up study. Vaccine. 2017;35(1):101–108.
   PubMed Web of Science ®Google Scholar
• Imai C, Li L, Hardie RA, et al. Adherence to guideline-recommended HbA1c testing frequency and better outcomes in patients with type 2 diabetes: a 5-year retrospective cohort study in Australian general practice. BMJ Qual Saf. Published online 2021 Feb 4;30(9):706–714.
   PubMed Web of Science ®Google Scholar
• Hatef E, Vanderver BG, Fagan P, et al. Annual diabetic eye examinations in a managed care Medicaid population. Am J Manag Care. 2015;21(5):e297–302.
   PubMed Web of Science ®Google Scholar
• Lian J, Liang Y. Diabetes management in the real world and the impact of adherence to guideline recommendations. Curr Med Res Opin. 2014;30(11):2233–2240.
   PubMed Web of Science ®Google Scholar
• Centers for Medicare & Medicaid Services. Value-based payment modifier program experience report.2018. Baltimore, MD, Centers for Medicare & Medicaid Services. Department of Health and Human Services.
   Google Scholar
• Massing MW, Henley NS, Carter-Edwards L, et al. Lipid testing among patients with diabetes who receive diabetes care from primary care physicians. Diabetes Care. 2003;26(5):1369–1373.
   PubMed Web of Science ®Google Scholar
• Vamos EP, Pape UJ, Curcin V, et al. Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes. Cmaj. 2016;188(14):E342–E351.
   PubMed Web of Science ®Google Scholar
• Suckow BD, Newhall KA, Bekelis K, et al. Hemoglobin A1c testing and amputation rates in black, hispanic, and white medicare patients. Ann Vasc Surg. 2016;36:208–217.
   PubMed Web of Science ®Google Scholar
• Goodney Philip P, Newhall Karina A, Kimon B, et al. Consistency of hemoglobin a1c testing and cardiovascular outcomes in medicare patients with diabetes. J Am Heart Assoc. 2016;5(8):e003566.
   PubMed Web of Science ®Google Scholar
• Phillips LS, Branch WT, Cook CB, et al. Clinical Inertia. Ann Intern Med. 2001;135(9):825.
   PubMed Web of Science ®Google Scholar
• Brunton S. Therapeutic inertia is a problem for all of US. Clin Diabetes. 2019;37(2):105–106.
   PubMedGoogle Scholar
• Moser M. Physician or clinical inertia: what is it? Is it really a problem? And what can be done about it? J Clin Hypertens (Greenwich). 2009;11(1):1–4.
   PubMed Web of Science ®Google Scholar
• Calvin JE, Shanbhag S, Avery E, et al. Adherence to evidence-based guidelines for heart failure in physicians and their patients: lessons from the heart failure adherence retention trial (HART). Congest Heart Fail. 2012;18(2):73–78.
   PubMedGoogle Scholar
• Knighton AJ, McLaughlin M, Blackburn R, et al. Increasing adherence to evidence-based clinical practice. Qual Manage Healthcare. 2019;28(1):65–67.
   PubMed Web of Science ®Google Scholar
• Nagpal J, Sachdeva A, Sengupta Dhar R, et al. Widespread non-adherence to evidence-based maternity care guidelines: a population-based cluster randomised household survey. Bjog. 2015;122(2):238–247.
   PubMed Web of Science ®Google Scholar
• Okemah J, Peng J, Quiñones M. Addressing clinical inertia in Type 2 diabetes mellitus: a review. Adv Ther. 2018;35(11):1735–1745.
   PubMed Web of Science ®Google Scholar
• Bloom F, Yan X, Stewart W, et al. Primary care diabetes bundle management: 3-year outcomes for microvascular and macrovascular events. Am J Manag Care. 2014;20(6):e175–e183.
   PubMed Web of Science ®Google Scholar
• Kelley E. All or none measurement: why we know so little about the comprehensiveness of care. Int J Qual Health Care. 2007;19(1):1–3.
   PubMed Web of Science ®Google Scholar
• Mangione CM, Gerzoff RB, Williamson DF, et al. The association between quality of care and the intensity of diabetes disease management programs. Ann Intern Med. 2006;145(2):107–116.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 1. Strategies for improving care. Diabetes Care. 2016;39(Supplement_1): S6–S12.
   PubMed Web of Science ®Google Scholar
• Wan EYF, Fung CSC, Jiao FF, et al. Five-year effectiveness of the multidisciplinary risk assessment and management programme–diabetes mellitus (RAMP-DM) on diabetes-related complications and health service uses—a population-based and propensity-matched cohort study. Diabetes Care. 2018;41(1):49–59.
   PubMed Web of Science ®Google Scholar
• Ortegon MM, Redekop WK, Niessen LW. Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis. Diabetes Care. 2004;27(4):901–907.
   PubMed Web of Science ®Google Scholar
• Vijan S, Hofer TP, Hayward RA. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA. 2000;283(7):889–896.
   PubMed Web of Science ®Google Scholar
• Canedo JR, Miller ST, Schlundt D, et al. Racial/ethnic disparities in diabetes quality of care: the role of healthcare access and socioeconomic status. J Racial Ethn Health Disparities. 2018;5(1):7–14.
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey Home. [internet] 2021. [cited 2021 Nov 1]. Available from: https://www.meps.ahrq.gov/mepsweb
   Google Scholar
• Agency for Healthcare Research and Quality. MEPS HC-210. [internet] 2019. [cited 2021 Nov 1]. Available from: https://www.meps.ahrq.gov/data_stats/download_data/pufs/h210/h210doc.shtml
   Google Scholar
• Agency for Healthcare Research and Quality. MEPS A survey about your diabetes care. [internet] 2019. [cited 2021 Nov 1]. Available from: https://meps.ahrq.gov/survey_comp/hc_survey/paper_quest/2018/2018_DCS_ENG.shtml
   Google Scholar
• National Library of Medicine. Multum MediSource Lexicon (MMSL) Source Information. [internet] 2021. [cited 2021 Nov 1. Available from: https://www.nlm.nih.gov/research/umls/rxnorm/sourcereleasedocs/mmsl.html
   Google Scholar
• US Food and Drug Administration. National Drug Code Directory, [internet] 2020. Available from: https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory
   Google Scholar
• The National Center for Health Statistics (NCHS). ICD - ICD-10-CM - international classification of diseases, tenth revision, clinical modification. [internet], 2020. [cited 2021 Nov 1]. Available from: https://www.cdc.gov/nchs/icd/icd10cm.htm
   Google Scholar
• Lewing B, Abughosh SM, Lal LS, et al. Patient, physician, and health system factors associated with five types of inadequate care during management of type-2 diabetes mellitus in the United States. Diabetes Epidemiology and Management. 2022;6:100046.
   Google Scholar
• Glasheen WP, Renda A, Dong Y. Diabetes Complications Severity Index (DCSI)—Update and ICD-10 translation. J Diabetes Complications. 2017;31(6):1007–1013.
   PubMed Web of Science ®Google Scholar
• Department of Health and Human Services. Federal Poverty Level (FPL), [internet] 2021. [cited 2021 Nov 1]. Available from: https://www.healthcare.gov/glossary/federal-poverty-level-fpl
   Google Scholar
• Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care. 1998 Jan;36(1):8–27.
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality. MEPS HC-201 2017 Full Year Consolidated Data File. [internet] 2019. [cited 2021 Nov 1]. Available from: https://meps.ahrq.gov/data_stats/download_data/pufs/h201/h201doc.pdf
   Google Scholar
• Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36(1):1–10.
   PubMed Web of Science ®Google Scholar
• US Bureau of Labor Statistics. Consumer Price Index Home. [internet] 2021. [cited 2021 Nov 1. Available from: https://www.bls.gov/cpi
   Google Scholar
• Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Communications in Statistics - Simulation and Computation. 2009;38(6):1228–1234.
   Web of Science ®Google Scholar
• Nguyen T-L, Collins GS, Spence J, et al. Double-adjustment in propensity score matching analysis: choosing a threshold for considering residual imbalance. BMC Med Res Methodol. 2017;17(1):78.
   PubMed Web of Science ®Google Scholar
• Ali SN, Dang-Tan T, Valentine WJ, et al. Evaluation of the clinical and economic burden of poor glycemic control associated with therapeutic inertia in patients with Type 2 diabetes in the United States. Adv Ther. 2020;37(2):869–882.
   PubMed Web of Science ®Google Scholar
• Bain SC, Bekker Hansen B, Hunt B, et al. Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK. J Med Econ. 2020;23(1):98–105.
   PubMed Web of Science ®Google Scholar
• Rossi MCE, Lucisano G, Comaschi M, et al. Quality of diabetes care predicts the development of cardiovascular events: results of the AMD-QUASAR study. Diabetes Care. 2011;34(2):347–352.
   PubMed Web of Science ®Google Scholar
• Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299–1307.
   PubMed Web of Science ®Google Scholar
• DiBonaventura M, Wintfeld N, Huang J, et al. The association between nonadherence and glycated hemoglobin among type 2 diabetes patients using basal insulin analogs. Patient Prefer Adherence. 2014;8:873–882.
   PubMed Web of Science ®Google Scholar
• Roebuck MC, Liberman JN, Gemmill-Toyama M, et al. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff (Millwood). 2011;30(1):91–99.
   PubMed Web of Science ®Google Scholar
• Folkerts K, Petruski-Ivleva N, Comerford E, et al. Adherence to chronic kidney disease screening guidelines among patients with type 2 diabetes in a us administrative claims database. Mayo Clin Proc. 2021;96(4):975–986.
   PubMed Web of Science ®Google Scholar
• Ueki K, Sasako T, Okazaki Y, et al. Multifactorial intervention has a significant effect on diabetic kidney disease in patients with type 2 diabetes. Kidney Int. 2021;99(1):256–266.
   PubMed Web of Science ®Google Scholar